ResearcherSheng Jing HospitalActive in the last 2 years

Zhen Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8440-2554; OpenAlex author ID A5100412071. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

A glycan superbinder reveals polysialylated-CD56 as a precision biomarker for pancreatic cancer. Last author DOI 10.1073/pnas.2611747123 ↗
Pancreatic Cancer Progression Is Regulated by IPO7/p53/LncRNA MALAT1/MiR-129-5p Positive Feedback Loop. Co-author DOI 10.3389/fcell.2021.630262 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lingrui Huang · 1 shared paper, 2026 · strength 0.28
- Paper A glycan superbinder reveals polysialylated-CD56 as a precision biomarker for pancreatic cancer. DOI 10.1073/pnas.2611747123 ↗
Qinyun Sun · 1 shared paper, 2021 · strength 0.16
- Paper Pancreatic Cancer Progression Is Regulated by IPO7/p53/LncRNA MALAT1/MiR-129-5p Positive Feedback Loop. DOI 10.3389/fcell.2021.630262 ↗
Jin Xu · 1 shared paper, 2021 · strength 0.16
- Paper Pancreatic Cancer Progression Is Regulated by IPO7/p53/LncRNA MALAT1/MiR-129-5p Positive Feedback Loop. DOI 10.3389/fcell.2021.630262 ↗
Lan Cheng · 1 shared paper, 2021 · strength 0.16
- Paper Pancreatic Cancer Progression Is Regulated by IPO7/p53/LncRNA MALAT1/MiR-129-5p Positive Feedback Loop. DOI 10.3389/fcell.2021.630262 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.